Company Quick10K Filing
Zoetis
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 483 $54,569
10-K 2020-02-13 Annual: 2019-12-31
10-Q 2019-11-07 Quarter: 2019-09-30
10-Q 2019-08-06 Quarter: 2019-08-06
10-Q 2019-05-02 Quarter: 2019-03-31
10-K 2019-02-14 Annual: 2018-12-31
10-Q 2018-11-01 Quarter: 2018-09-30
10-Q 2018-08-02 Quarter: 2018-06-30
10-Q 2018-05-02 Quarter: 2018-03-31
10-K 2018-02-15 Annual: 2017-12-31
10-Q 2017-11-02 Quarter: 2017-10-01
10-Q 2017-08-08 Quarter: 2017-07-02
10-Q 2017-05-04 Quarter: 2017-04-02
10-K 2017-02-16 Annual: 2016-12-31
10-Q 2016-11-03 Quarter: 2016-10-02
10-Q 2016-08-05 Quarter: 2016-07-03
10-Q 2016-05-06 Quarter: 2016-04-03
10-K 2016-02-24 Annual: 2015-12-31
10-Q 2015-11-05 Quarter: 2015-09-27
10-Q 2015-08-06 Quarter: 2015-06-28
10-Q 2015-05-07 Quarter: 2015-03-29
10-K 2015-02-27 Annual: 2014-12-31
10-Q 2014-11-10 Quarter: 2014-09-28
10-Q 2014-08-12 Quarter: 2014-06-29
10-Q 2014-05-13 Quarter: 2014-03-30
10-K 2014-03-26 Annual: 2013-12-31
10-Q 2013-11-13 Quarter: 2013-09-29
10-Q 2013-08-14 Quarter: 2013-06-30
10-Q 2013-05-15 Quarter: 2013-03-31
10-K 2013-03-28 Annual: 2012-12-31
8-K 2020-02-13 Earnings, Exhibits
8-K 2020-02-11 Regulation FD, Exhibits
8-K 2019-12-11 Regulation FD, Exhibits
8-K 2019-12-09 Officers, Exhibits
8-K 2019-11-07 Earnings, Exhibits
8-K 2019-10-03 Regulation FD, Exhibits
8-K 2019-10-02 Officers, Other Events, Exhibits
8-K 2019-08-06 Earnings, Exhibits
8-K 2019-05-15 Shareholder Vote, Regulation FD, Exhibits
8-K 2019-05-02 Earnings, Exhibits
8-K 2019-02-14 Earnings, Exhibits
8-K 2019-02-12 Regulation FD, Exhibits
8-K 2018-12-12 Regulation FD, Exhibits
8-K 2018-11-01 Earnings, Exhibits
8-K 2018-10-10 Regulation FD, Exhibits
8-K 2018-08-20 Leave Agreement, Other Events, Exhibits
8-K 2018-08-02 Earnings, Exhibits
8-K 2018-07-31 M&A, Other Events, Exhibits
8-K 2018-07-27 Enter Agreement, Off-BS Arrangement
8-K 2018-07-06 Other Events, Exhibits
8-K 2018-05-16 Enter Agreement, Other Events, Exhibits
8-K 2018-05-15 Shareholder Vote, Regulation FD, Exhibits
8-K 2018-05-02 Earnings, Exhibits
8-K 2018-02-15 Earnings, Exhibits
8-K 2018-02-13 Regulation FD, Exhibits
8-K 2018-01-08 Regulation FD

Zoetis Financials

ZTS Metrics, Comps, Filings

Annual | Quarterly

Business

Zoetis Inc. is a global leader in the discovery, development, manufacture and commercialization of animal health medicines, vaccines, and diagnostic products with a focus on both livestock and companion animals. We have a diversified business, commercializing products across eight core species: cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals); and within six major product categories: vaccines, anti-infectives, parasiticides, medicated feed additives, animal health diagnostics and other pharmaceutical products. For more than 65 years, we have been committed to enhancing the health of animals and bringing solutions to our customers who raise and care for them.

The animal health medicines, vaccines and diagnostics market is characterized by meaningful differences in customer needs across different regions. This is due to a variety of factors, including:

-economic differences, such as standards of living in developed markets as compared to emerging markets;


Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Stockholders' Equity

Income Statement ($BB Annual)

Revenue, Gross Profit, Net Income

Cash Flow ($BB Annual)

Operating, Investing, Financing

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
AbbVie (ABBV) 100,912 77% 18.0 7% 57,142 65,708 32,624 25,254 4,118 7,085 127,359
Beigene (BGNE) 98,573 88% -152.1 -31% 2,150 579 434 383 -664 -642 97,723
Bristol Myers Squibb (BMY) 73,829 53% 8.4 11% 55,163 39,012 23,857 12,640 6,226 8,365 69,858
Celgene (CELG) 67,154 96% 10.4 13% 39,183 29,132 16,354 15,736 5,271 7,702 79,730
GW Pharmaceuticals (GWPH) 64,239 88% -1,554.6 -6% 843 114 114 100 -50 -41 63,656
Allergan (AGN) 54,767 85% 80.8 -4% 123,846 38,273 15,678 13,341 -5,356 939 75,841
Zoetis (ZTS) 54,569 67% 25.9 13% 10,986 8,575 6,046 4,046 1,375 2,291 59,314
Sanofi (SNY) 52,845 0% 111,408 0 0 0 0 52,184
Vertex Pharmaceuticals (VRTX) 46,842 87% 16.9 33% 7,033 1,964 3,454 2,990 2,355 2,569 43,540
Regeneron Pharmaceuticals (REGN) 35,984 0% 15.2 16% 13,174 3,418 7,237 0 2,069 2,295 34,925
Alexion Pharmaceuticals (ALXN) 28,246 71% 15.7 9% 14,568 4,404 4,499 3,191 1,334 1,835 28,827
Biomarin Pharmaceutical (BMRN) 15,774 79% 680.7 -3% 4,393 1,432 1,533 1,213 -110 24 16,336
Elanco Animal Health (ELAN) 12,085 52% 30.6 2% 8,857 3,591 3,073 1,591 144 460 14,098
Mylan (MYL) 9,779 34% 8.3 0% 31,817 19,914 11,245 3,793 34 2,748 22,896
Teva (TEVA) 9,708 44% -13.7 -6% 59,424 44,173 17,720 7,741 -3,851 -2,437 33,498
Sarepta Therapeutics (SRPT) 9,465 0% -16.1 -33% 1,748 649 345 0 -570 -518 8,352
Ionis Pharmaceuticals (IONS) 9,097 57% 30.7 17% 2,878 1,421 799 459 495 287 8,825
Sage Therapeutics (SAGE) 8,814 51% -14.1 -47% 1,316 113 2 1 -613 -612 8,646
Bausch (BHC) 8,750 0% 25.1 -3% 32,354 29,666 8,425 0 -911 1,285 32,239
Alnylam Pharmaceuticals (ALNY) 7,978 91% -8.0 -32% 2,716 959 101 92 -858 -856 6,838

Balance Sheet ($MM)2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Cash6108821,1547271,5641,602
Accounts Receivable1,1389809379139981,036
Inventory1,2931,2891,4671,5021,4271,391
PP&E2,3231,3181,3071,3811,4351,658
Assets6,5586,6077,9137,6498,58610,777
Accounts Payable506290293265261313
Long-Term Debt3,6523,6534,9004,5005,0006,500
Liabilities5,5965,2706,8226,1506,8008,592
Stockholders' Equity9401,3111,0681,4871,7702,185
Income Statement ($MM)2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Revenue4,5614,7854,7654,8885,3075,825
Cost of Revenue1,6691,7171,7381,6661,7751,911
Gross Profit2,8923,0683,0273,2223,5323,914
R&D399396364376382432
SG&A1,6131,6431,5321,3641,3341,484
Tax187278224408663266
Net Income5035873398198621,424
Cash Flow ($MM)2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Cash Operating6816266647131,3461,790
Cash Investing-179-187-1,115-214-270-2,259
Cash Financing-200-154755-903-251533